<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39334454</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1824-7288</ISSN><JournalIssue CitedMedium="Internet"><Volume>50</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>27</Day></PubDate></JournalIssue><Title>Italian journal of pediatrics</Title><ISOAbbreviation>Ital J Pediatr</ISOAbbreviation></Journal><ArticleTitle>Asymptomatic SARS-COV2 Infection or COVID-19 vaccination effect for severe multisystem inflammatory syndrome in a 6-year-old girl: case report and review of the literature.</ArticleTitle><Pagination><StartPage>194</StartPage><MedlinePgn>194</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">194</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13052-024-01758-y</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Multisystem Inflammatory Syndrome in Children (MIS-C) is a rare complication, which develops within 3-6 weeks after SARS-CoV2 infection. The coronavirus disease 2019 (COVID-19) vaccine was firstly introduced in adults and adolescents and later in patients aged 5-11 years old. Although a reduced incidence of MIS-C and with less severe symptoms has been reported in vaccinated adolescents, there is little knowledge in children younger than 12 years of age. In addition, it is not understood whether MIS-C in vaccinated patients can be triggered by Covid19 vaccination or be secondary to a recent asymptomatic Sars-Cov2 infection.</AbstractText><AbstractText Label="CASE PRESENTATION" NlmCategory="METHODS">We describe the case of a Caucasian 6-year-old girl, one month after double COVID-19 vaccination, who presented fever, acute abdominal pain, rash, pharyngotonsillitis, cheilitis, cervical lymphadenopathy without a prior detected Sars-Cov2 infection. She also had lymphopenia, increase in inflammatory markers, cardiac and pulmonary involvement. Therefore, we dosed both anti Sars-Cov2 Spike and Nucleocapsid antibodies, which were positive and allowed us to confirm the diagnosis of MIS-C. We promptly administered intravenous immunoglobulins and methylprednisone, resulting in the initial regression of fever. During the hospitalization, the child also developed pancreatitis and severe neurological involvement, including irritability, drowsiness, distal tremor, dyskinesia and buccal asymmetry with complete resolution after 2 months. After 3 months from the onset of the symptoms, she reported a transient loss of hair compatible with telogen effluvium. After 12 months of follow-up, she did not show any symptomatic sequelae.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This case raises the question of whether COVID-19 vaccination may be involved in the pathogenesis of MIS-C in children between the ages of 5 and 11 years old.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Manca</LastName><ForeName>Enrica</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-8723-0129</Identifier><AffiliationInfo><Affiliation>Pediatrics Department, University Hospital of Foggia, Foggia, Italy. enricamanca@hotmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IDESP, UA11-INSERM, University of Montpellier, Montpellier, France. enricamanca@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>di Toma</LastName><ForeName>Michele</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Pediatrics Department, University Hospital of Foggia, Foggia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Esotico</LastName><ForeName>Marianna</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University of Foggia, Foggia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soldano</LastName><ForeName>Lucia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Pediatrics Department, University Hospital of Foggia, Foggia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Polito</LastName><ForeName>Anna Nunzia</ForeName><Initials>AN</Initials><AffiliationInfo><Affiliation>Department of Woman and Child, Neuropsychiatry for Child and Adolescent Unit, University Hospital of Foggia, Foggia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mongelli</LastName><ForeName>Giuseppina</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Pediatrics Department, University Hospital of Foggia, Foggia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guglielmi</LastName><ForeName>Leonardo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>University of Foggia, Foggia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scaltrito</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>University of Foggia, Foggia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campanozzi</LastName><ForeName>Angelo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Pediatrics Department, University Hospital of Foggia, Foggia, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Foggia, Foggia, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Ital J Pediatr</MedlineTA><NlmUniqueID>101510759</NlmUniqueID><ISSNLinking>1720-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C000705967">pediatric multisystem inflammatory disease, COVID-19 related</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018746" MajorTopicYN="Y">Systemic Inflammatory Response Syndrome</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058345" MajorTopicYN="N">Asymptomatic Infections</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Case report</Keyword><Keyword MajorTopicYN="N">Children</Keyword><Keyword MajorTopicYN="N">MIS-C</Keyword><Keyword MajorTopicYN="N">Vaccination</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>0</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39334454</ArticleId><ArticleId IdType="pmc">PMC11438245</ArticleId><ArticleId IdType="doi">10.1186/s13052-024-01758-y</ArticleId><ArticleId IdType="pii">10.1186/s13052-024-01758-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dufort EM, Koumans EH, Chow EJ, et al. Multisystem inflammatory syndrome in children in New York State. N Engl J Med. 2020;23383:347–58. 10.1056/NEJMoa2021756.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7346766</ArticleId><ArticleId IdType="pubmed">32598830</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel JM. Multisystem inflammatory syndrome in children (MIS-C). Curr Allergy Asthma Rep. 2022;22:53–60. 10.1007/s11882-022-01031-4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8938222</ArticleId><ArticleId IdType="pubmed">35314921</ArticleId></ArticleIdList></Reference><Reference><Citation>La Torre F, Elicio MP, Monno VA, et al. Incidence and prevalence of Multisystem Inflammatory Syndrome in Children (MIS-C) in Southern Italy. Child (Basel). 2023;10:766. 10.3390/children10050766.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10217079</ArticleId><ArticleId IdType="pubmed">37238314</ArticleId></ArticleIdList></Reference><Reference><Citation>De Henriques-Souza M, de Melo AM, de Aguiar Coelho Silva Madeiro ACMG. B, Acute disseminated encephalomyelitis in a COVID-19 pediatric patient. Neuroradiology 202;63:141–5. 10.1007/s00234-020-02571-0</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7527786</ArticleId><ArticleId IdType="pubmed">33001220</ArticleId></ArticleIdList></Reference><Reference><Citation>Tam H, El Tal T, Go E, et al. Pediatric inflammatory multisystem syndrome temporally associated with COVID-19: a spectrum of diseases with many names. CMAJ. 2020;192(38). 10.1503/cmaj.201600.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7532008</ArticleId><ArticleId IdType="pubmed">32907819</ArticleId></ArticleIdList></Reference><Reference><Citation>Fabi M, Filice E, Biagi C et al. Multisystem Inflammatory Syndrome Following SARS-CoV-2 Infection in Children: One Year after the Onset of the Pandemic in a High-Incidence Area. Viruses. 2021;13:2022. 10.3390/v13102022</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8541388</ArticleId><ArticleId IdType="pubmed">34696451</ArticleId></ArticleIdList></Reference><Reference><Citation>Payne AB, Gilani Z, Godfred-Cato S, et al. Incidence of Multisystem Inflammatory Syndrome in Children among US persons infected with SARS-CoV-2. JAMA Netw Open. 2021;4:e2116420. 10.1001/jamanetworkopen.2021.16420.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8193431</ArticleId><ArticleId IdType="pubmed">34110391</ArticleId></ArticleIdList></Reference><Reference><Citation>Siracusa L, Cascio A, Giordano S, et al. Neurological complications in pediatric patients with SARS-CoV-2 infection: a systematic review of the literature. Ital J Pediatr. 2021;47:123. 10.1186/s13052-021-01066-9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8170632</ArticleId><ArticleId IdType="pubmed">34078441</ArticleId></ArticleIdList></Reference><Reference><Citation>Olivotto S, Basso E, Lavatelli R, et al. Acute encephalitis in pediatric multisystem inflammatory syndrome associated with COVID-19. Eur J Paediatr Neurol. 2021;34:84–90. 10.1016/j.ejpn.2021.07.010.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8339542</ArticleId><ArticleId IdType="pubmed">34425479</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen TH. Neurological involvement associated with COVID-19 infection in children. J Neurol Sci. 2020;418:117096. 10.1016/j.jns.2020.117096.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7423535</ArticleId><ArticleId IdType="pubmed">32823135</ArticleId></ArticleIdList></Reference><Reference><Citation>LaRovere KL, Riggs BJ, Poussaint TY, et al. Neurologic involvement in children and adolescents hospitalized in the United States for COVID-19 or Multisystem Inflammatory Syndrome. JAMA Neurol. 2021;78:536–47. 10.1001/jamaneurol.2021.0504.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7936352</ArticleId><ArticleId IdType="pubmed">33666649</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannattasio A, Maglione M, D’Anna C, et al. Liver and pancreatic involvement in children with multisystem inflammatory syndrome related to SARS-CoV-2: a Monocentric Study. Child (Basel). 2022;9:575. 10.3390/children9040575.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9029098</ArticleId><ArticleId IdType="pubmed">35455620</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohyama M, Matsudo K, Fujita T. Management of hair loss after severe acute respiratory syndrome coronavirus 2 infection: insight into the pathophysiology with implication for better management. J Dermatol. 2022;49:939–47. 10.1111/1346-8138.16475.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9348110</ArticleId><ArticleId IdType="pubmed">35633047</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayran Y, Yorulmaz A, Gür G, et al. Different hair loss patterns in two pediatric patients with COVID-19-associated multisystem inflammatory syndrome in children. Dermatol Ther. 2021;34:e14820. 10.1111/dth.14820.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7995128</ArticleId><ArticleId IdType="pubmed">33506994</ArticleId></ArticleIdList></Reference><Reference><Citation>Savaş Şen Z, Polat M, Öz FN, et al. Hair loss as a late complication of Multisystem Inflammatory Syndrome in Children. Pediatr Infect Dis J. 2021;40:e251–2. 10.1097/INF.0000000000003115.</Citation><ArticleIdList><ArticleId IdType="pubmed">33633001</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballow M. The IgG molecule as a biological immune response modifier: mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders. J Allergy Clin Immunol. 2011;127:315–23. 10.1016/j.jaci.2010.10.030.</Citation><ArticleIdList><ArticleId IdType="pubmed">21185071</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamad Saied M, van der Griend L, van Straalen JW, et al. The protective effect of COVID-19 vaccines on developing multisystem inflammatory syndrome in children (MIS-C): a systematic literature review and meta-analysis. Pediatr Rheumatol Online J. 2023;21:80. 10.1186/s12969-023-00848-1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10405572</ArticleId><ArticleId IdType="pubmed">37550719</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Multisystem inflammatory syndrome in children and adolescents temporally related to COVID-19 Published May 15, 2020. Accessed January 10, 2024. https://www.who.int/publications/i/item/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19</Citation></Reference><Reference><Citation>Santos MO, Gonçalves LC, Silva PAN, et al. Multisystem inflammatory syndrome (MIS-C): a systematic review and meta-analysis of clinical characteristics, treatment, and outcomes. J Pediatr (Rio J). 2022;98:338–49. 10.1016/j.jped.2021.08.006.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9432310</ArticleId><ArticleId IdType="pubmed">34863701</ArticleId></ArticleIdList></Reference><Reference><Citation>Bova SM, Serafini L, Capetti P, et al. Neurological involvement in Multisystem Inflammatory Syndrome in Children: clinical, Electroencephalographic and Magnetic Resonance Imaging Peculiarities and therapeutic implications. An Italian single-center experience. Front Pediatr. 2022;10:932208. 10.3389/fped.2022.932208.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9411661</ArticleId><ArticleId IdType="pubmed">36034550</ArticleId></ArticleIdList></Reference><Reference><Citation>Fink EL, Robertson CL, Wainwright MS, et al. Prevalence and risk factors of neurologic manifestations in Hospitalized Children diagnosed with Acute SARS-CoV-2 or MIS-C. Pediatr Neurol. 2022;128:33–44. 10.1016/j.pediatrneurol.2021.12.010.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8713420</ArticleId><ArticleId IdType="pubmed">35066369</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuccotti G, Calcaterra V, Mannarino S, et al. Six-month multidisciplinary follow-up in multisystem inflammatory syndrome in children: an Italian single-center experience. Front Pediatr. 2023;10:1080654. 10.3389/fped.2022.1080654.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9909209</ArticleId><ArticleId IdType="pubmed">36776681</ArticleId></ArticleIdList></Reference><Reference><Citation>Czech T, Sugihara S, Nishimura Y. Characteristics of hair loss after COVID-19: a systematic scoping review. J Cosmet Dermatol. 2022;21:3655–62. 10.1111/jocd.15218.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9349634</ArticleId><ArticleId IdType="pubmed">35801366</ArticleId></ArticleIdList></Reference><Reference><Citation>Cattalini M, Taddio A, Bracaglia C, et al. Childhood multisystem inflammatory syndrome associated with COVID-19 (MIS-C): a diagnostic and treatment guidance from the Rheumatology Study Group of the Italian society of pediatrics. Ital J Pediatr. 2021;47(1):24. 10.1186/s13052-021-00980-2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7868856</ArticleId><ArticleId IdType="pubmed">33557873</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmoud S, El-Kalliny M, Kotby A, et al. Treatment of MIS-C in children and adolescents. Curr Pediatr Rep. 2022;10:1–10. 10.1007/s40124-021-00259-4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8741532</ArticleId><ArticleId IdType="pubmed">35036079</ArticleId></ArticleIdList></Reference><Reference><Citation>DeBiasi RL. Immunotherapy for MIS-C - IVIG, glucocorticoids, and Biologics. N Engl J Med. 2021;385:74–5. 10.1056/NEJMe2108276.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8362545</ArticleId><ArticleId IdType="pubmed">34133878</ArticleId></ArticleIdList></Reference><Reference><Citation>Henderson LA, Canna SW, Friedman KG, et al. American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated with SARS-CoV-2 and Hyperinflammation in Pediatric COVID-19: version 2. Arthritis Rheumatol. 2021;73:e13–29. 10.1002/art.41616.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8559788</ArticleId><ArticleId IdType="pubmed">33277976</ArticleId></ArticleIdList></Reference><Reference><Citation>McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and long-term management of Kawasaki Disease: A Scientific Statement for Health professionals from the American Heart Association. Circulation. 2017;135:e927–99. 10.1161/CIR.0000000000000484.</Citation><ArticleIdList><ArticleId IdType="pubmed">28356445</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharathkumar AA, Faustino EVS, Takemoto CM. How we approach thrombosis risk in children with COVID-19 infection and MIS-C. Pediatr Blood Cancer. 2021;68:e29049. 10.1002/pbc.29049.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8206673</ArticleId><ArticleId IdType="pubmed">33955167</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldstein LR, Tenforde MW, Friedman KG, et al. Adolescents with Multisystem Inflammatory Syndrome in Children (MIS-C) compared with severe Acute COVID-19. JAMA. 2021;325(11):1074–87. 10.1001/jama.2021.2091.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7905703</ArticleId><ArticleId IdType="pubmed">33625505</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevens JP, Brownell JN, Freeman AJ, et al. COVID-19-associated Multisystem Inflammatory Syndrome in Children presenting as Acute Pancreatitis. J Pediatr Gastroenterol Nutr. 2020;71(5):669–71. 10.1097/MPG.0000000000002860.</Citation><ArticleIdList><ArticleId IdType="pubmed">33093376</ArticleId></ArticleIdList></Reference><Reference><Citation>Alves R, Grimalt R. Hair loss in children. Curr Probl Dermatol. 2015;47(3):55–66. 10.1159/000369405.</Citation><ArticleIdList><ArticleId IdType="pubmed">26370644</ArticleId></ArticleIdList></Reference><Reference><Citation>Mieczkowska K, Deutsch A, Borok J, et al. Telogen effluvium: a sequela of COVID-19. Int J Dermatol. 2021;60:122–4. 10.1111/ijd.15313.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7753411</ArticleId><ArticleId IdType="pubmed">33226117</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi A, Magri F, Sernicola A, et al. Telogen Effluvium after SARS-CoV-2 infection: a series of cases and possible pathogenetic mechanisms. Skin Appendage Disord. 2021;21:1–5. 10.1159/000517223.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8339054</ArticleId><ArticleId IdType="pubmed">34373830</ArticleId></ArticleIdList></Reference><Reference><Citation>Feleszko W, Okarska-Napierała M, Buddingh EP, et al. Pathogenesis, immunology, and immune-targeted management of the multisystem inflammatory syndrome in children (MIS-C) or pediatric inflammatory multisystem syndrome (PIMS): EAACI position paper. Pediatr Allergy Immunol. 2023;34:e13900. 10.1111/pai.13900.</Citation><ArticleIdList><ArticleId IdType="pubmed">36705045</ArticleId></ArticleIdList></Reference><Reference><Citation>La Torre F, Taddio A, Conti C, et al. Multi-inflammatory syndrome in children (MIS-C) in 2023: is it time to forget about it? Child (Basel). 2023;10:980. 10.3390/children10060980.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10297102</ArticleId><ArticleId IdType="pubmed">37371212</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogel TP, Top KA, Karatzios C, et al. Multisystem inflammatory syndrome in children and adults (MIS-C/A): case definition &amp; guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine. 2021;39(22):3037–49. 10.1016/j.vaccine.2021.01.054.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7904456</ArticleId><ArticleId IdType="pubmed">33640145</ArticleId></ArticleIdList></Reference><Reference><Citation>Noval Rivas M, Porritt RA, Cheng MH, et al. Multisystem inflammatory syndrome in children and long COVID: the SARS-CoV-2 viral Superantigen hypothesis. Front Immunol. 2022;13:941009. 10.3389/fimmu.2022.941009.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9300823</ArticleId><ArticleId IdType="pubmed">35874696</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiss SL, Carcillo JA, Leclerc F, et al. Refining the Pediatric multiple organ dysfunction syndrome. Pediatrics. 2022;149:S13–22. 10.1542/peds.2021-052888C.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9084565</ArticleId><ArticleId IdType="pubmed">34970671</ArticleId></ArticleIdList></Reference><Reference><Citation>Sperotto F, Gutiérrez-Sacristán A, Makwana S, et al. Clinical phenotypes and outcomes in children with multisystem inflammatory syndrome across SARS-CoV-2 variant eras: a multinational study from the 4CE consortium. EClinicalMedicine. 2023;64:102212. 10.1016/j.eclinm.2023.102212.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10511777</ArticleId><ArticleId IdType="pubmed">37745025</ArticleId></ArticleIdList></Reference><Reference><Citation>Holm M, Espenhain L, Glenthøj J, et al. Risk and phenotype of Multisystem Inflammatory Syndrome in Vaccinated and unvaccinated Danish children before and during the Omicron Wave. JAMA Pediatr. 2022;176:821–3. 10.1001/jamapediatrics.2022.2206.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9178498</ArticleId><ArticleId IdType="pubmed">35675054</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy N, Koppel JH, Kaplan O, et al. Severity and incidence of Multisystem Inflammatory Syndrome in Children during 3 SARS-CoV-2 pandemic waves in Israel. JAMA. 2022;327:2452–4. 10.1001/jama.2022.8025.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9121298</ArticleId><ArticleId IdType="pubmed">35588048</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller AD, Yousaf AR, Bornstein E, et al. Multisystem inflammatory syndrome in children (MIS-C) during severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV-2) Delta and Omicron variant circulation—United States, July 2021–January 2022. Clin Infect Dis. 2022;75:S303–7. 10.1093/cid/ciac471.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9214171</ArticleId><ArticleId IdType="pubmed">35684958</ArticleId></ArticleIdList></Reference><Reference><Citation>Molloy MJ, Auger KA, Hall M, et al. Epidemiology and severity of illness of MIS-C and Kawasaki Disease during the COVID-19 pandemic. Pediatrics. 2023;e2023062101. 10.1542/peds.2023-062101. Online ahead of print.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10598633</ArticleId><ArticleId IdType="pubmed">37791428</ArticleId></ArticleIdList></Reference><Reference><Citation>Zambrano LD, Newhams MM, Olson SM, et al. BNT162b2 mRNA vaccination against COVID-19 is associated with decreased likelihood of multisystem inflammatory syndrome in U.S. children ages 5–18 years. Clin Infect Dis. 2023;76:e90–100. 10.1093/cid/ciac637.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9384630</ArticleId><ArticleId IdType="pubmed">35924406</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy M, Recher M, Hubert H, et al. Multisystem inflammatory syndrome in children by COVID-19 vaccination status of adolescents in France. JAMA. 2022;327:281–3. 10.1001/jama.2021.23262.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8689418</ArticleId><ArticleId IdType="pubmed">34928295</ArticleId></ArticleIdList></Reference><Reference><Citation>Yousaf AR, Miller AD, Lindsey K et al. Multisystem inflammatory syndrome in children among persons who completed a two-dose COVID-19 vaccine primary series compared with those reporting no COVID-19 vaccination, US National MIS-C surveillance. Pediatr Infect Dis J. 2023 Sep 12. doi: 10.1097/INF.0000000000004103. Online ahead of print. 10.1097/INF.0000000000004103</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11262462</ArticleId><ArticleId IdType="pubmed">37725819</ArticleId></ArticleIdList></Reference><Reference><Citation>Consolini R, Costagliola G, Spada E, et al. Case Report: MIS-C with prominent hepatic and pancreatic involvement in a vaccinated adolescent - A critical reasoning. Front Pediatr. 2022;10:896903. 10.3389/fped.2022.896903.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9149168</ArticleId><ArticleId IdType="pubmed">35652054</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Elslande J, Oyaert M, Ailliet S, et al. Longitudinal follow-up of IgG anti-nucleocapsid antibodies in SARS-CoV-2 infected patients up to eight months after infection. J Clin Virol. 2021;136:104765. 10.1016/j.jcv.2021.104765.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7891078</ArticleId><ArticleId IdType="pubmed">33636554</ArticleId></ArticleIdList></Reference><Reference><Citation>Liguori V, Zinzi A, Gaio M, et al. Multisystem inflammatory syndrome in children following COVID-19 vaccination: a sex-stratified analysis of the VAERS database using Brighton collaboration Criteria. Pharmaceuticals (Basel). 2023;16(9):1231. 10.3390/ph16091231.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10535674</ArticleId><ArticleId IdType="pubmed">37765039</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortese MM, Taylor AW, Akinbami LJ, et al. Surveillance for Multisystem Inflammatory Syndrome in US children aged 5–11 years who received Pfizer-BioNTech COVID-19 vaccine, November 2021 through March 2022. J Infect Dis. 2023;228(2):143–8. 10.1093/infdis/jiad051.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10563003</ArticleId><ArticleId IdType="pubmed">36821777</ArticleId></ArticleIdList></Reference><Reference><Citation>Wangu Z, Swartz H, Doherty M. Multisystem inflammatory syndrome in children (MIS-C) possibly secondary to COVID-19 mRNA vaccination. BMJ Case Rep. 2022;15(3):e247176. 10.1136/bcr-2021-247176.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8968554</ArticleId><ArticleId IdType="pubmed">35354564</ArticleId></ArticleIdList></Reference><Reference><Citation>Haq K, Anyalechi EG, Schlaudecker EP, et al. Multiple MIS-C readmissions and giant coronary aneurysm after COVID-19 illness and vaccination: a Case Report. Pediatr Infect Dis J. 2023;42(3):e64–9. 10.1097/INF.0000000000003801.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9935235</ArticleId><ArticleId IdType="pubmed">36729556</ArticleId></ArticleIdList></Reference><Reference><Citation>Demharter NS, Rao P, Scalzi LV, et al. Prolonged Thrombocytopenia in a case of MIS-C in a Vaccinated child. J Investig Med High Impact Case Rep. 2023;11:23247096221145104. 10.1177/23247096221145104. Online ahead of print.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9829881</ArticleId><ArticleId IdType="pubmed">36594290</ArticleId></ArticleIdList></Reference><Reference><Citation>Saeed S, Cao J, Xu J, et al. Case Report: a case of multisystem inflammatory syndrome in an 11-year-old female after COVID-19 inactivated vaccine. Front Pediatr. 2023;11:1068301. 10.3389/fped.2023.1068301.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9972091</ArticleId><ArticleId IdType="pubmed">36865693</ArticleId></ArticleIdList></Reference><Reference><Citation>Yalçinkaya R, Öz FN, Polat M, et al. A case of multisystem inflammatory syndrome in a 12-year-old male after COVID-19 mRNAvaccine. Pediatr Infect Dis J. 2022;41:e87–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8828314</ArticleId><ArticleId IdType="pubmed">34978781</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelgalil AA, Saeedi FA. Multisystem inflammatory syndrome in a 12-year-old boy after mRNA-SARS-CoV-2 vaccination. Pediatr Infect Dis J. 2022;41:e93–4. 10.1097/INF.0000000000003442.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8828311</ArticleId><ArticleId IdType="pubmed">34955518</ArticleId></ArticleIdList></Reference><Reference><Citation>Poussaint TY, LaRovere KL, Newburger JW. Multisystem inflammatory-like syndrome in a child following COVID-19 mRNA vaccination. Vaccines (Basel). 2021;10(1):43. 10.3390/vaccines10010043.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8781649</ArticleId><ArticleId IdType="pubmed">35062704</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S, Ardoin SP, Blaney C, et al. Multisystem inflammatory syndrome in children after breakthrough infection in a COVID-19-vaccinated child. Pediatr Infect Dis J. 2022;41(4):e182–3. 10.1097/INF.0000000000003451.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8919944</ArticleId><ArticleId IdType="pubmed">34974479</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJong J, Sainato R, Forouhar M, et al. Multisystem inflammatory syndrome in a previously vaccinated adolescent female with sickle cell disease. Pediatr Infect Dis J. 2022;41:e104–5. 10.1097/INF.0000000000003444.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8828312</ArticleId><ArticleId IdType="pubmed">34955521</ArticleId></ArticleIdList></Reference><Reference><Citation>Hugh McGann P, Krim AOA, Green J. Multi inflammatory syndrome in a16-year-old male following first dose of m-RNA COVID-19 vaccination. Clin Infect Pract 2022 Apr:14:100139. 10.1016/j.clinpr.2022.100139</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8843319</ArticleId><ArticleId IdType="pubmed">35187466</ArticleId></ArticleIdList></Reference><Reference><Citation>Chai Q, Nygaard U, Schmidt RC, et al. Multisystem inflammatory syndrome in a male adolescent after his second Pfizer-BioNTech COVID-19 vaccine. Acta Paediatr. 2022;111:125–7. 10.1111/apa.16141.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8653123</ArticleId><ArticleId IdType="pubmed">34617315</ArticleId></ArticleIdList></Reference><Reference><Citation>Karatzios C, Scuccimarri R, Chédeville G, et al. Multisystem inflammatory syndrome following SARS-CoV-2 vaccination in two children. Pediatrics. 2022;150(2):e2021055956. 10.1542/peds.2021-055956.</Citation><ArticleIdList><ArticleId IdType="pubmed">35614536</ArticleId></ArticleIdList></Reference><Reference><Citation>Collignon C, Frachette C, Callot D, et al. Two pediatric cases of multisystem inflammatory-like syndrome following COVID-19 vaccination. Arch Pediatr. 2022;29(8):620–3. 10.1016/j.arcped.2022.08.018.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9510064</ArticleId><ArticleId IdType="pubmed">36283888</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain E, Donowitz JR, Aarons E, et al. Multisystem inflammatory syndrome in children after SARS-CoV-2 vaccination. Emerg Infect Dis. 2022;28(5):990–3. 10.3201/eid2805.212418.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9045439</ArticleId><ArticleId IdType="pubmed">35275051</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>